Weight / GLP-1 · Nov 11, 2026
Common Side Effects of GLP-1 Medications and How to Manage Them
Learn how to recognize, track, and manage common GLP-1 side effects like nausea, constipation, and diarrhea. Discover practical strategies and tracking tips to minimize discomfort and support your treatment journey.
By Michelle Pearlman, MD, Gastroenterologist & ByteMD co-founder
For those using GLP-1 receptor agonists (e.g., semaglutide, liraglutide, tirzepatide) to manage obesity or diabetes—especially when using a tracking approach like BYTEMD—it's crucial to understand common side effects and how to mitigate them.
Most Common GI-Related Side Effects
According to the JAMA article:
- Nausea: Affects ~33%–44% of users, often early in treatment
- Diarrhea: ~23%–31% incidence
- Vomiting: Seen in ~11%–25% of users
- Constipation: Affects ~17%–23%
- Indigestion (dyspepsia): Reported by ~9%
These side effects are usually mild to moderate and resolve as the body adjusts—especially during dose titration.
Less Common but Serious Adverse Effects
While rare, GLP-1 users should be aware of:
- Pancreatitis
- Gastroparesis (delayed stomach emptying)
- Bowel obstruction
- Gallbladder complications (e.g., gallstones)
Seek immediate care if you experience persistent nausea, sharp abdominal pain, jaundice, or inability to pass gas/stool.
Psychiatric & Other Emerging Side Effects
Additional observations from real-world use and studies include:
- Psychiatric symptoms: Anxiety, insomnia, eating disorders (~4.5% in adverse reports)
- Physical changes: Hair loss, dry mouth, altered taste perception, and facial fat loss ("Ozempic face")
- Vision risks: Rare cases of nonarteritic anterior ischemic optic neuropathy (NAION) reported
These side effects, while less common, may still require intervention or specialist referral.
Strategies to Minimize Adverse Events
| Strategy | Description |
|---|---|
| 1. Slow Dose Titration | Gradually increase dosage to reduce GI discomfort. |
| 2. Adjust Diet | Eat smaller, slower meals; avoid high-fat foods; chew thoroughly. |
| 3. Stay Hydrated | Prevent dehydration—especially with diarrhea or vomiting. |
| 4. Add Fiber | Helps manage constipation; combine with hydration. |
| 5. Space Activity & Meals | Avoid exercise right after meals. |
| 6. Supplement Wisely | Consider calcium, B12, vitamin D, and protein if losing weight rapidly. |
| 7. Monitor Closely | Track symptoms; seek help for severe GI, vision, or mental health symptoms. |
BYTEMD: Tracking to Identify Triggers
For users employing the BYTEMD action plan (tracking food intake and GI symptoms), integration with GLP-1 medications helps pinpoint and manage triggers:
| Step | Application |
|---|---|
| Track Food | Record meals and snacks with timing. |
| Log GI Symptoms | Note any nausea, bloating, diarrhea, etc., within 1–2 hours. |
| Monitor Dose Changes | Flag when side effects arise relative to dosage increases. |
| Adjust Accordingly | Identify food or timing patterns that correlate with adverse events. |
| Share Logs | Bring symptom logs to appointments for personalized care. |
Key Takeaways
- Most common side effects: nausea, vomiting, constipation, and diarrhea (9–44% range)
- Less frequent but serious: pancreatitis, gallbladder disease, vision problems, and mental health issues
- Minimization: slow dose escalation, dietary changes, hydration, nutrient tracking, and use of personal food-symptom logs
- Integration tip: Use structured tracking like BYTEMD to uncover patterns, prevent flare-ups, and fine-tune care
Citation
Kushner RF, Almandoz JP, Rubino DM. Managing Adverse Effects of Incretin-Based Medications for Obesity. JAMA. Published online July 29, 2025. doi: 10.1001/jama.2025.11153